MK-8133

From WikiMD's Wellness Encyclopedia

MK-8133

MK-8133 is an investigational pharmaceutical compound developed by Merck & Co. It is primarily being studied for its potential use in the treatment of various cardiovascular diseases. As a novel agent, MK-8133 is part of a class of drugs known as PCSK9 inhibitors, which are designed to lower low-density lipoprotein cholesterol (LDL-C) levels in the blood.

Mechanism of Action[edit | edit source]

MK-8133 functions by inhibiting the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that plays a crucial role in cholesterol metabolism. PCSK9 binds to LDL receptors on the surface of liver cells, leading to their degradation. By inhibiting PCSK9, MK-8133 increases the number of LDL receptors available to clear LDL-C from the bloodstream, thereby reducing overall cholesterol levels.

Clinical Development[edit | edit source]

MK-8133 is currently undergoing clinical trials to evaluate its efficacy and safety in patients with hypercholesterolemia. Early-phase studies have shown promising results in terms of LDL-C reduction, with ongoing trials aiming to establish its long-term benefits and potential side effects.

Phase I Trials[edit | edit source]

The initial Phase I trials focused on assessing the safety, tolerability, and pharmacokinetics of MK-8133 in healthy volunteers. These studies demonstrated that MK-8133 was well-tolerated at various dose levels, with a favorable safety profile.

Phase II Trials[edit | edit source]

Subsequent Phase II trials involved patients with elevated LDL-C levels who were at high risk for cardiovascular events. The trials aimed to determine the optimal dosing regimen and further evaluate the drug's efficacy in reducing LDL-C levels.

Phase III Trials[edit | edit source]

Phase III trials are designed to confirm the efficacy and safety of MK-8133 in a larger patient population. These trials are critical for obtaining regulatory approval and typically involve comparisons with existing standard-of-care treatments.

Potential Benefits[edit | edit source]

MK-8133 offers several potential benefits for patients with high cholesterol levels, particularly those who are unable to achieve target LDL-C levels with statins alone. By providing an alternative mechanism of action, MK-8133 may help reduce the risk of atherosclerotic cardiovascular disease in these patients.

Side Effects[edit | edit source]

As with any investigational drug, MK-8133 may have side effects. Commonly reported adverse effects in clinical trials include injection site reactions, nasopharyngitis, and upper respiratory tract infections. Ongoing studies continue to monitor for any long-term safety concerns.

Regulatory Status[edit | edit source]

As of the latest updates, MK-8133 is not yet approved for clinical use and remains under investigation in clinical trials. The results of these trials will determine its future availability and use in clinical practice.

Also see[edit | edit source]

FlattenedRoundPills.jpg
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Cardiovascular disease A-Z

Most common cardiac diseases

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A[edit source]

B[edit source]

C[edit source]

D[edit source]

E[edit source]

H[edit source]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I[edit source]

K[edit source]

L[edit source]

M[edit source]

N[edit source]

O[edit source]

P[edit source]

R[edit source]

S[edit source]

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T[edit source]

V[edit source]

W[edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD